They have to release when the results are in no pick ang choosing. I'm still waiting for how they are going to fund themselves forward. Good news on 944 front though
But tighter controls on Vicodin to reduce access to the addicted and those not really needing it does not increase the market for non opiod pain killers. It just reduces the market for Vicodin etc.. . Z160 is not a replacement for the lost market share as it is not addictive and those users are not looking so much for pain relief. Jmho
So how does that help Zalicus?
Lol. Did not allow long enough for the pump crew article. This company still needs funds.... Work it out. Look at funds at end of last quarter, you add LC deduct encumberments and quarterly burn rate... They will raise funds soon.
Sold at 4.07. Still feeling spooked by lack of current funding at this point and that trials currently only phase 2 and 1...long way to go. Too risky for me at the moment. Would like to see funding solution in place for more than a year.
I'm still on the sidelines as I believe they will soon announce their next funding strategy. Then we drop below this 4.8 support weekly uptrend... Maybe? Who knows.. .
Whilst those help they do not cover the cash burn. And no one here surely believes they won't need more cash to fund potential further trials
Seen this with other bios and zalicus has a high cash burn rate. It makes sense to raise cash before results in case they are not favourable.
I sold the last of my meagre shares at 1.19 yesterday, and will likely reaquire once things settle. . . Watch for a share offer soon IMHO
No idea but I did sell 80% of my meagre shares today. Long way to go still but still like this company